| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/1997 | WO1997048382A2 Multiple-unit type prolonged action drug preparation |
| 12/24/1997 | WO1997048381A1 Pharmaceutical preparation in the form of liposomes |
| 12/24/1997 | WO1997048380A1 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS |
| 12/24/1997 | WO1997048379A1 Nasal administration of desmopressin |
| 12/24/1997 | WO1997048369A2 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | WO1997044065A3 Device and method for encapsulated gene therapy |
| 12/24/1997 | WO1997042963A3 Green ointment |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997040824A3 Propellant mixtures and aerosols for micronising medicaments with compressed gas |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997038699A3 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | CN1168678A Method of treating diabetes mellitus using KGF |
| 12/24/1997 | CN1168636A Liposomal agents |
| 12/24/1997 | CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof |
| 12/24/1997 | CN1168630A Medicaments |
| 12/24/1997 | CN1168629A Adjuvant for a vaccine composition |
| 12/24/1997 | CN1168621A Stable, optically clear compositions |
| 12/24/1997 | CN1168284A Chinese medicine bolus Dingfengwan and its prepn process |
| 12/24/1997 | CN1168283A Chinese pharmaceutical made of single medicinal material |
| 12/24/1997 | CN1168277A Eyesight granule and its compounding process |
| 12/24/1997 | CN1168269A External-use anti-cancer ointment |
| 12/24/1997 | CN1036763C Pharmaceutical composition pharmaceutical granulate and process for their preparation |
| 12/24/1997 | CA2258736A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | CA2258709A1 Controlled release tablet |
| 12/24/1997 | CA2258552A1 Nasal administration of desmopressin |
| 12/24/1997 | CA2258242A1 Device for topical treatment of acne and its method of manufacture |
| 12/24/1997 | CA2258099A1 Insulin preparations containing carbohydrates |
| 12/24/1997 | CA2257405A1 Administration regimen of h+, k+-atpase inhibitors |
| 12/24/1997 | CA2253285A1 Pharmaceutical preparation in the form of liposomes |
| 12/23/1997 | US5700998 Method of delivering a drug pill to a patient |
| 12/23/1997 | US5700929 Base for coating solid enteric pharmaceutical preparations |
| 12/23/1997 | US5700848 Gel compositions prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor |
| 12/23/1997 | US5700836 Topically administering to treat photodamaged skin |
| 12/23/1997 | US5700823 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 12/23/1997 | US5700822 Treatment of platelet derived growth factor related disorders such as cancers |
| 12/23/1997 | US5700814 Active material, carrier, ph in range 8 to 10; alzheimer's disease |
| 12/23/1997 | US5700679 Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity |
| 12/23/1997 | US5700662 Culturing a genetic engineered host cell, gene expressing a dna, encoding a proinsulin, enzymatically disconnecting |
| 12/23/1997 | US5700583 Hydrogels of absorbable polyoxaesters containing amines or amido groups |
| 12/23/1997 | US5700514 Lozenges comprising binder and erythritol or maltitol as sweetener and process of making |
| 12/23/1997 | US5700486 Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions |
| 12/23/1997 | US5700485 Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| 12/23/1997 | US5700484 Sustained release microparticulate caffeine formulation |
| 12/23/1997 | US5700483 Retinoic acid-containing compositions |
| 12/23/1997 | US5700482 Subjecting to a mobile carrier phase consisting of carbon dioxide and a polar organic solvent under supercritical pressure and temperature conditions; reducing pressure; transferring to aqueous phase |
| 12/23/1997 | US5700480 Having impermeable backing layer, pressure sensitive adhesive reservoir layer comprising polyacrylate, plasticizer, galanthamine base or salt |
| 12/23/1997 | US5700478 Comprising water soluble polymer and miscible water soluble plasticizer having specified properties |
| 12/23/1997 | US5700471 Production of fine particle dye or drug preparations |
| 12/23/1997 | US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor |
| 12/23/1997 | US5700449 Capsule of coating comprising agar and dentifrice encapsulated in coating |
| 12/23/1997 | US5700410 Method of manufacturing wax matrices |
| 12/23/1997 | CA2178637C Paroxetine tablets and process to prepare them |
| 12/23/1997 | CA2052901C Pharmacologically enhanced formulations |
| 12/23/1997 | CA2025855C Pharmaceutical compositions having activity on the cutaneous microcirculation |
| 12/23/1997 | CA2012791C Spray gel base and spray gel preparation |
| 12/20/1997 | CA2208332A1 Drug administration composition for iontophoresis |
| 12/20/1997 | CA2208298A1 Effervescent system for effervescent tablets and effervescent granules and process for the preparation of the effervescent system |
| 12/20/1997 | CA2208174A1 Squalene synthetase inhibitors |
| 12/18/1997 | WO1997047751A1 Human dnase i hyperactive variants |
| 12/18/1997 | WO1997047577A1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 12/18/1997 | WO1997047370A1 Microfabricated filter and method of making same |
| 12/18/1997 | WO1997047353A1 Composition and system for iontophoretic transdermal delivery of drugs |
| 12/18/1997 | WO1997047333A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | WO1997047324A1 Method of using aloe vera as a biological vehicle |
| 12/18/1997 | WO1997047323A2 Chitosan drug delivery system |
| 12/18/1997 | WO1997047322A1 Medical powder |
| 12/18/1997 | WO1997047320A1 Immunstimulating lipid formulation |
| 12/18/1997 | WO1997047311A1 Coated compositions containing polyene derivatives |
| 12/18/1997 | WO1997047310A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |
| 12/18/1997 | WO1997047305A1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine |
| 12/18/1997 | WO1997047304A1 Fast-dissolving galanthamine hydrobromide tablet |
| 12/18/1997 | WO1997047292A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | WO1997047291A1 Adhesive patch for lithium controlled release |
| 12/18/1997 | WO1997047290A1 Liquisolid systems and methods of preparing same |
| 12/18/1997 | WO1997047289A1 Stabilized hinokitiol and compositions containing same |
| 12/18/1997 | WO1997047288A1 Microencapsulated fragrances and method for preparation |
| 12/18/1997 | WO1997047287A1 Intraorally rapidly disintegrable tablet |
| 12/18/1997 | WO1997047286A1 Medicinal aerosol formulations of formoterol |
| 12/18/1997 | WO1997047285A1 Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| 12/18/1997 | WO1997047278A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof |
| 12/18/1997 | WO1997047171A1 Skin wash composition |
| 12/18/1997 | WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/18/1997 | WO1997028104A8 Buffer systems for use in stabilizing pharmaceutical preparations |
| 12/18/1997 | WO1997025052A3 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 12/18/1997 | DE19623950A1 Pharmazeutische Zubereitung in Form von Liposomen Pharmaceutical composition in the form of liposomes |
| 12/18/1997 | DE19623440A1 Immobilised organic material with defined release of active agent |
| 12/18/1997 | DE19623410A1 Agglomeration of poorly soluble and hydrolysis sensitive materials |
| 12/18/1997 | CA2258264A1 Microencapsulated fragrances and method for preparation |
| 12/18/1997 | CA2258092A1 Medical powder |
| 12/18/1997 | CA2257990A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | CA2257913A1 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine |
| 12/18/1997 | CA2257902A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | CA2257850A1 Stabilized hinokitiol and compositions containing same |
| 12/18/1997 | CA2255680A1 Composition and system for iontophoretic transdermal delivery of drugs |
| 12/18/1997 | CA2234969A1 Adhesive patch for lithium controlled release |
| 12/18/1997 | CA2229981A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |
| 12/18/1997 | CA2228251A1 Chitosan drug delivery system |
| 12/17/1997 | EP0812893A2 Antimicrobial hot melt adhesive composition |
| 12/17/1997 | EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |